23 Nov Crispin Blunt Asks Parliamentary Question On Medicinal Cannabis, 22nd November 2016.

Crispin Blunt MP

Crispin Blunt MP

Q. To ask the Secretary of State for Health, whether (a) his Department and (b) the Medicine and Healthcare Products Regulatory Agency has reviewed the latest evidence, including evidence on different regulatory approaches in other jurisdictions, for the use of medical cannabis.

nicola-blackwood-in-hoc

Nicola Blackwood MP. Minister Of State For Health

A. The Medicines and Healthcare products Regulatory Agency (MHRA) reviews evidence submitted by a company seeking a marketing authorisation for a medicinal product in the United Kingdom. One product containing extracts of cannabis, Sativex, has been licensed as a medicinal product by the MHRA. However, no such application has been received in respect of herbal cannabis, and therefore the MHRA has undertaken no review of the evidence for its medicinal use. Outwith the MHRA licensing process, the Department has not conducted or commissioned a review of herbal cannabis or its regulation in other jurisdictions.

Source

  • Sowel

    So in order for them to even look at the medical benifits we need a company to submit to MHRA requesting market authorisation..
    Now we know what the next step needs to be how hard will it be to set it up? Can we send in numerous requests from many companies?

  • rexter

    We supply quality medical/recreational marijuana,cannabis oil ,hash oil, hemp oil, Rick Simpson oil, wax oil ,concentrates ,hemp incense and cartridges .Contact us at [email protected] for your marijuana needs….. Wickr id : kunweed